BioNTech sues Moderna for patent infringement over COVID shots - Business Insurance

Article ID: c48f1ad024c437699dc4892df125102748ad50a0675cd2318e2190a4159ad81c

Source ID: secondary:businessinsurance.com

Published At: -

Extraction Method: bs4_heuristic

URL: https://www.businessinsurance.com/biontech-sues-moderna-for-patent-infringement-over-covid-shots/

Body Text

BioNTech sues Moderna for patent infringement over COVID shots - Business Insurance Skip to content Register for free Search Search Log In Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers BioNTech sues Moderna for patent infringement over COVID shots Intellectual Property , Technology Feb 20, 2026 (Reuters) — German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna’s COVID-19 vaccine mNEXSPIKE infringes a patent related to BioNTech and Pfizer’s competing shot Comirnaty. The lawsuit said that mNEXSPIKE, Moderna’s next-generation COVID shot approved by the U.S. Food and Drug Administration in 2025, violates BioNTech’s rights in technology for a streamlined messenger RNA-based vaccine design that can be given to patients at a lower dosage. Moderna sued BioNTech and its partner Pfizer for patent infringement over Comirnaty in 2022, in a lawsuit that is ongoing. The cases are among a wave of patent lawsuits from biotech companies seeking royalties for the technology used in the blockbuster vaccines. A Moderna spokesperson said that the company would defend itself against BioNTech’s case. BioNTech did not immediately respond to a request for comment on the new lawsuit. Spokespeople for Pfizer, which is not directly involved in the lawsuit, also did not immediately comment. mNEXSPIKE is expected to account for 55% of Moderna’s COVID vaccine revenue through the 2025-26 respiratory virus season, BioNTech’s lawsuit said. COVID vaccine revenues have dropped sharply since the height of the pandemic, when Moderna’s Spikevax and Pfizer and BioNTech’s Comirnaty earned the companies billions in revenue. Vaccine revenues in general have also slumped following U.S. President Donald Trump’s appointment of vaccine skeptic Robert F. Kennedy Jr. as health secretary. Related News Amwins unveils hospitality practice to support retail brokers February 19, 2026 Court limits scope of pollution exclusion in herbicide case February 19, 2026 Chubb names new chief actuary February 19, 2026 Being tracked keeps drivers on track February 19, 2026 OSHA cites US Steel for fatal coke works explosion February 19, 2026 Alabama employer cited after sewer worker deaths February 19, 2026 RIMS to press lawmakers on litigation funding, foreign-backed suits February 19, 2026 Westfield Specialty reports $1.93B in gross written premium February 19, 2026 Va. House passes bill to cover exacerbation of mental health conditions February 19, 2026 Facebook-f X-twitter Linkedin-in Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing. Never miss important news: Become a Business Insurance Online subscriber today Subscribe Now Information About Us Contact Advertise Privacy Policy Terms & Conditions Copyright 2026. BUSINESS INSURANCE HOLDINGS Member, Beacon International Group, Ltd.

Metadata (JSON)

{
  "score": 11.716666666666667
}